Stress Urinary Incontinence (SUI): Causes, Diagnosis, and Treatment Options

Stress Urinary Incontinence (SUI) is the involuntary leakage of urine during activities that increase intra-abdominal pressure—coughing, sneezing, laughing, lifting, or exercise. It affects an estimated 15–35% of women; it is less common in men, typically occurring post-prostatectomy.

Pathophysiology

Two primary mechanisms:

  • Urethral Hypermobility: Loss of pelvic floor support allows the urethra to descend during stress, preventing adequate closure.
  • Intrinsic Sphincter Deficiency (ISD): The urethral sphincter is incompetent and cannot coapt (close) properly despite adequate support.

Risk Factors

  • Female sex, vaginal childbirth (especially forceps, prolonged second stage)
  • Age, menopause (estrogen loss leads to mucosal atrophy)
  • Obesity (increases intra-abdominal pressure)
  • Chronic cough (COPD, asthma), constipation, heavy lifting
  • Pelvic surgery (hysterectomy), radiation
  • Neurological disorders, connective tissue disorders
  • Smoking (cough, collagen degradation)

Diagnostic Evaluation

  • History: Leakage triggers, volume, impact on QoL (validated questionnaires: ICIQ-UI SF, UDI-6).
  • Physical Exam: Pelvic exam (POP-Q), cough stress test (supine/standing), post-void residual (PVR) measurement.
  • Urinalysis/Culture: If indicated.
  • Urodynamics: For complex cases (Valsalva leak point pressure, urethral pressure profilometry).

Treatment Algorithm

Conservative (First-Line)

  • Pelvic Floor Muscle Training (PFMT): Kegels, biofeedback, weighted cones; 3–6 month trial.
  • Lifestyle: Weight loss, smoking cessation, fluid management, treat constipation/cough.
  • Vaginal Pessaries / Urethral Inserts: Mechanical support.
  • Topical Estrogen: For postmenopausal women (improves mucosal integrity).

Pharmacologic

  • Duloxetine (SNRI) – off-label in US; approved in EU for SUI. Modest benefit, side effects (nausea).

Surgical (Refractory Cases)

  • Midurethral Sling (Retropubic/Transobturator): Gold standard; >85% cure at 1 year.
  • Burch Colposuspension: Open/laparoscopic; durable but more invasive.
  • Bulking Agents: For ISD; lower durability.
  • Artificial Urinary Sphincter (Male SUI): High success, revision risk.

Prognosis and Follow-Up

Conservative therapy improves symptoms in 50–70%. Surgical success exceeds 80% at 5 years. Annual follow-up for symptom recurrence, mesh complications (if sling), and QoL assessment is recommended.

Urinary Disorders - Related Articles